首页|小剂量艾司氯胺酮联合右美托咪定对乳腺癌根治手术后患者睡眠及恢复的影响

小剂量艾司氯胺酮联合右美托咪定对乳腺癌根治手术后患者睡眠及恢复的影响

扫码查看
目的:观察小剂量艾司氯胺酮联合右美托咪定对乳腺癌根治术患者术后睡眠及恢复情况.方法:选择择期行乳腺癌改良根治术的女性90 例,年龄30~65 岁,BMI18~28kg/m2,ASA Ⅰ~Ⅲ级.采用随机数字表法将患者分成两组,对照组C组,艾司氯胺酮联合右美托咪定组ED组,每组45 例.两组麻醉诱导和前锯肌平面阻滞方法一致,术毕均实施PCIA.麻醉维持:C组术中静脉泵注丙泊酚和瑞芬太尼4~6mg/kg/h;ED组术中静脉泵注丙泊酚、右美托咪定0.05μg/kg/h及艾司氯胺酮0.2mg/kg/h,两组均维持BIS为40~60.根据麻醉深度及术中血压调整药物,间断推注顺式阿曲库铵0.06mg/kg.采用腕表式睡眠监测仪(Actiwatch)和睡眠日志记录患者术前 1 天、术后 1 天和术后 3 天的睡眠情况;采用匹兹堡睡眠质量指数量表、医院焦虑抑郁量表及QoR-40 量表评估术前 1 天、术后 1 天和术后3 天的恢复情况,同时记录不良反应的发生.结果:与C组比较,ED组术后 1 天和术后3 天总睡眠时间和睡眠效率明显改善(P<0.05);夜间觉醒次数低(P<0.05);ED组的术后 3天焦虑抑郁评分较C组低(P<0.05);且ED组术后3 天的QoR-40 评分较C组高(P<0.05).结论:小剂量艾司氯胺酮联合右美托咪定可缓解乳腺癌患者术后疼痛,减少阿片类药物的使用,不增加不良反应的发生,同时改善患者术后睡眠质量,提高患者术后恢复质量.
Effect of Mini-Dose Esketamine Combined with Dexmedetomidine on Sleep and Recovery in Patients after Radical Breast Cancer Surgery
Objective:To observe the effect of low-dose esketamine combined with dexmedetomidine on postoperative sleep and recovery in patients undergoing radical mastectomy for breast cancer.Methods:90 women aged 30 ~65,BMI 18 ~28 kg/m2 ,ASA physical status Ⅰ ~Ⅲ.Patients were randomly divided into two groups:control group (Group C)and esketamine combined with dexmedetomidine (Group ED),with 45 cases in each group.The induction of anesthesia and anterior serratus plane block were the same in both groups,and PCIA was performed at the end of surgery.Maintenance of anesthesia:Propofol and remifentanil in Group C; and propofol,dexmedetomidine,and esketamine in Group ED,and BIS was maintained at 40 ~60 in both group.Cisatracurium was injected intermittently according to anesthetic depth and intraoperative blood pressure.The watch-type sleep monitor (Actiwatch)and sleep logs were used to record patients'sleep at 1day preoperatively,1 day postoperative and 3days postoperative.The Pittsburgh Sleep Quality Index Scale,Hospital Anxiety and Depression Scale and Qor-40 Scale were used to assess the recovery of the patients,and the incidence of adverse reactions was recorded.Results:Compared with Group C,the total sleep time and sleep efficiency were significantly improved in the Group ED at 1day and 3days postoperatively (P<0.05),the number of nocturnal awakening was low (P< 0.05),the anxiety and depression score in the Group ED at 3 days postoperatively were lower than those in Group C(P<0.05),and the QoR-40 score in Group ED at 3days postoperatively was higher than that in group C (P<0.05 ).Conclusion:Low -dose esketamine combined with dexmedetomidine can relieve the postoperative pain of breast cancer patients,reduce the use of opioid drugs,and improve the quality of postoperative sleep and recovery without increasing the incidence of adverse effects.

Low-dose esketamineSleep disordersPainAnxiety and depression

孙袁鸣、夏晓琼、高翔、陶志国

展开 >

安徽医科大学附属巢湖医院 麻醉科(安徽 巢湖 238000)

小剂量艾司氯胺酮 睡眠障碍 疼痛 焦虑抑郁

安徽省卫生健康委科研项目

AHWJ2020b155

2024

黑龙江医药
黑龙江省药品审评认证中心

黑龙江医药

影响因子:0.597
ISSN:1006-2882
年,卷(期):2024.37(1)
  • 4